GB1464797A - Injectable liquid vitamin preparation - Google Patents

Injectable liquid vitamin preparation

Info

Publication number
GB1464797A
GB1464797A GB2978674A GB2978674A GB1464797A GB 1464797 A GB1464797 A GB 1464797A GB 2978674 A GB2978674 A GB 2978674A GB 2978674 A GB2978674 A GB 2978674A GB 1464797 A GB1464797 A GB 1464797A
Authority
GB
United Kingdom
Prior art keywords
preparation
vitamin
niacinamide
calculated
preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2978674A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of GB1464797A publication Critical patent/GB1464797A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/28—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
    • A61M5/284—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle comprising means for injection of two or more media, e.g. by mixing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31596—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms comprising means for injection of two or more media, e.g. by mixing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M2005/1787—Syringes for sequential delivery of fluids, e.g. first medicament and then flushing liquid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/3129—Syringe barrels
    • A61M2005/3132—Syringe barrels having flow passages for injection agents at the distal end of the barrel to bypass a sealing stopper after its displacement to this end due to internal pressure increase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

1464797 Vitamin injections AMERICAN CYANAMID CO 4 July 1974 [2 Aug 1973] 29786/74 Heading A5B A stable aqueous multivitamin preparation consists of two incompatible aqueous vitamin preparations each held in a separate compartment of a two compartment syringe capable of consecutively injecting said preparations into a host, wherein one preparation is at a pH of 6.8 to 7.6 and contains 300 mg of sodium ascorbate (calculated as ascorbic acid), 1 mg folic acid and 20 mg niacinamide and the other preparation is at a pH of 4.5 to 5.5 and contains 10 mg thiamine, hydrochloride, 10 mg sodium riboflavin-5'-phosphate (calculated as riboflavin), 55 mg niacinamide, 10 mg d-panthenol, 15 mg of pyridoxine hydrochloride and 15 mcg cyanocobalamin. The first preparation may also include vitamin A palmitate, vitamin D2, and d-alpha-tocophenyl acetate.
GB2978674A 1973-08-02 1974-07-04 Injectable liquid vitamin preparation Expired GB1464797A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38499573A 1973-08-02 1973-08-02

Publications (1)

Publication Number Publication Date
GB1464797A true GB1464797A (en) 1977-02-16

Family

ID=23519605

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2978674A Expired GB1464797A (en) 1973-08-02 1974-07-04 Injectable liquid vitamin preparation

Country Status (8)

Country Link
JP (1) JPS5043789A (en)
AU (1) AU7105474A (en)
BE (1) BE818372A (en)
DE (1) DE2433440A1 (en)
ES (1) ES428890A1 (en)
FR (1) FR2239990B1 (en)
GB (1) GB1464797A (en)
NL (1) NL7409809A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0704199A1 (en) * 1994-04-20 1996-04-03 The Green Cross Corporation Transfusion container, transfusion preparation, and comprehensive vitamin-containing high-calorie transfusion preparation
FR2881052A1 (en) * 2005-01-26 2006-07-28 Becton Dickinson France Soc Pa Separate storage device for liquid substances, comprises hollow body, stoppers separated by a shutter and placed in the hollow portion of the body and chambers filled with the liquid substances
CN106039480A (en) * 2016-08-04 2016-10-26 山东威高集团医用高分子制品股份有限公司 Pre-filled syringe for continuous treatment
WO2017055462A1 (en) * 2015-10-02 2017-04-06 F. Hoffmann-La Roche Ag Multi chamber syringe unit and method of preparing a multi chamber syringe

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE15861T1 (en) * 1981-07-29 1985-10-15 Duphar Int Res INJECTION SYRINGE.
EP0072058A1 (en) * 1981-08-10 1983-02-16 Duphar International Research B.V Multiple-compartment syringe
EP0295337B1 (en) * 1987-06-16 1991-12-04 Akzo Nobel N.V. Two compartment syringe and method of manufacturing
JPH0620219B2 (en) * 1989-04-11 1994-03-16 松下電送株式会社 Document feeder release device
JPH0715552Y2 (en) * 1989-08-01 1995-04-12 武田薬品工業株式会社 Syringe type 2 component container
JP2942962B2 (en) * 1990-03-30 1999-08-30 株式会社バルダン Long cloth cutting device
FR2672868B1 (en) * 1991-02-15 1993-06-04 Pasteur Merieux Serums Vacc PROCESS FOR PACKAGING LYOPHILIZED VACCINES IN SYRINGE AND CAP FOR ITS IMPLEMENTATION.
AU725161B2 (en) * 1995-08-09 2000-10-05 Tetsuro Higashikawa Syringe, its sealing structure and sealing method and sliding valve for syringe
DE102004051245A1 (en) * 2004-10-20 2006-04-27 Aquanova German Solubilisate Technologies (Agt) Gmbh Vitamin C solubilisate
DE102017208255A1 (en) * 2017-05-16 2018-11-22 Vetter Pharma-Fertigung GmbH & Co. KG Medicament container having an end plug, use of a stopper securing member for securing an end plug in a medicament container and stopper securing member

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0704199A1 (en) * 1994-04-20 1996-04-03 The Green Cross Corporation Transfusion container, transfusion preparation, and comprehensive vitamin-containing high-calorie transfusion preparation
EP0704199A4 (en) * 1994-04-20 1998-04-22 Green Cross Corp Transfusion container, transfusion preparation, and comprehensive vitamin-containing high-calorie transfusion preparation
FR2881052A1 (en) * 2005-01-26 2006-07-28 Becton Dickinson France Soc Pa Separate storage device for liquid substances, comprises hollow body, stoppers separated by a shutter and placed in the hollow portion of the body and chambers filled with the liquid substances
WO2006079728A1 (en) * 2005-01-26 2006-08-03 Becton Dickinson France Method for mixing at least two substances, manufacturing method and applications
WO2017055462A1 (en) * 2015-10-02 2017-04-06 F. Hoffmann-La Roche Ag Multi chamber syringe unit and method of preparing a multi chamber syringe
CN108136128A (en) * 2015-10-02 2018-06-08 豪夫迈·罗氏有限公司 Injection syringe with multi-cavity chamber unit and the method for preparing injection syringe with multi-cavity chamber
US20180256818A1 (en) * 2015-10-02 2018-09-13 Hoffman-La Roche Inc. Multi chamber syringe unit and method of preparing a multi chamber syringe
CN108136128B (en) * 2015-10-02 2021-04-13 豪夫迈·罗氏有限公司 Multi-chamber syringe unit and method for preparing multi-chamber syringe
CN106039480A (en) * 2016-08-04 2016-10-26 山东威高集团医用高分子制品股份有限公司 Pre-filled syringe for continuous treatment

Also Published As

Publication number Publication date
BE818372A (en) 1975-02-03
FR2239990B1 (en) 1977-07-08
AU7105474A (en) 1976-01-15
NL7409809A (en) 1975-02-04
JPS5043789A (en) 1975-04-19
FR2239990A1 (en) 1975-03-07
DE2433440A1 (en) 1975-02-13
ES428890A1 (en) 1977-04-01

Similar Documents

Publication Publication Date Title
GB1464797A (en) Injectable liquid vitamin preparation
ES2007607A6 (en) An insulin preparation for non-parenteral administration.
DK0454898T3 (en) Glycosaminoglycan modified protein, method of producing the protein, pharmaceutical preparations containing the protein and use of the protein
US3914419A (en) Two compartment one unit consecutively injectable liquid vitamin package
GB1198764A (en) A Urate Oxidase and process for the production thereof
GB1420788A (en) Injectable preparations
DE69005398D1 (en) Pharmaceutical preparations containing topically cosmetically applicable depolymerized nucleic acids.
GB1235667A (en) Improvements in or relating to sustained release preparations
GB1164569A (en) Improvements in or relating to Antilipaemic Sulphated Polysaccharides
GB1351006A (en) Water-soluble konjac mannan and a process for the preparation thereof
Reaven et al. The use of insulin in the production of L-leucine-induced hypoglycemia in normal dogs
ES264510A1 (en) Improvements in or relating to pharmaceutical iron preparations
JPS5679622A (en) Antitumor pharmaceutical
GB1210968A (en) Improvements in or relating to the treatment of gastric ailments
GB1356096A (en) Mineral salt preparation
GB1460325A (en) Pharmaceutical composition intended for relieving pain and producing analgesia
Wick et al. Influence of glucose concentration on the action of insulin
GB1246315A (en) Pharmaceutical compositions
GB1293691A (en) TREATMENT OF MAREK'S DISEASE WITH p-AMINO-p'-UREIDODIPHENYL SULFONE
IE39264L (en) Pharmaceutical preparations.
GB1314956A (en) Chromone compounds
ES361702A1 (en) Dihydroorotic and Salts
GB1401896A (en) Composition for detecting succinodehydrogenase activity
GB1254744A (en) Antiviral ribonucleic acid substance
GB1356991A (en) Kanamycin a salts

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee